I think you might have misinterpreted my post and I obviously...

I think you might have misinterpreted my post and I obviously could have worded things better. I was speaking in general about biotechs getting ramped to the moon when they have no serious chance a commercial outcome, not about any specific company. The reference to a certain HC darling was in reference to the ramping going on right now, not its chance of commercial success which I don’t want to comment on here.

Good companies can be ramped as well as bad ones so I don’t think you should necessarily use the existence of ramping to mean anything more than the day traders are in the stock. Everyone should be cautious when there is a lot of exuberance in a stock as the price can get well out of alignment with the fundamental value, but sometimes the excitement is based on reality. Many of those people who though CSL was overvalued at $100 and sold are now regretting their decision.

Off topic, what crazy weather today in Sydney. I hope everyone is OK and nobody is flooded.